World Cancer Day
4th February 2025
Cancer touches millions of lives in countless ways but it doesn't define who they are. It is more than a disease, more than a statistic. The new World Cancer Day campaign 2025-27 “United by Unique” places people at the centre of care and will explore new ways of making a difference. It offers a three- year journey from raising awareness to taking action. World Cancer Day
UpToDate
UpToDate pathways
Cochrane Library
Guidelines
Online resources
Reports and statistics
Articles
Clinical
Research
Treatment and treatment related complications
E-books
Journals
__________________________________________________________________________________
Articles
Clinical
Association of optimism and social support with health-related quality of life among Australian women cancer survivors – A cohort study
These findings highlight a strong connection between optimism, social support, and health-related quality of life (HRQL) among cancer survivors. Providing psychosocial support and addressing behavioral and socioeconomic factors and other health conditions associated with optimism and social support may improve HRQL. Asia-Pacific journal of clinical oncology 21 May 2024
Cancer cachexia
What you need to know
BMJ 23 October 2024
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
Highlights
Vaccine 7 December 2024
COVID-19 vaccine hesitancy, acceptance and informational needs in an Australian cancer population: a cross-sectional survey
There is a need for tailored COVID-19 vaccine communication that is responsive to the concerns of people with cancer. This will be beneficial during current and future vaccination rollouts. Australian health review 8 December 2024
Perspectives on telemedicine visits reported by patients with cancer
In this survey study of perspectives on telemedicine visits, a large majority of patients at a comprehensive cancer center expressed satisfaction with telemedicine visits in proportions that remained consistent beyond the end of the pandemic. These findings challenge health care systems to integrate telemedicine into routine cancer care and to overcome remaining technical challenges and barriers to ease of use. JAMA 15 November 2024
Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta-analysis
Despite existing guidelines, pre-chemotherapy HBV screening rate remains unsatisfactory, with substantial heterogeneous rates globally. These findings underscore the need for effective strategies to align practices with clinical guidelines. Asia-Pacific journal of clinical oncology 21 March 2024
__________________________________________________________________________________
Research
25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis
Cancer mortality had a substantial reduction during the past 25 years in both men and women aged 35-69 years. This decline is likely a reflection of the successes in cancer prevention (eg, smoking prevention policies and cessation programmes), earlier detection (eg, screening programmes) and improved diagnostic tests, and more effective treatment. By contrast, increased prevalence of non-smoking risk factors are the likely cause of the observed increased incidence for a small number of specific cancers. This analysis also provides a benchmark for the following decade, which will include the impact of covid-19 on cancer incidence and outcomes. BMJ 13 March 2024
A metric for comparison and visualization of age disparities in cancer survival
Highlights
Cancer Epidemiology 18 May 2024
Co-occurrence of cancer and diabetes in a high-income country: Age-period-cohort projections 2020–2044
These findings reinforce the fact that diabetes prevention activities are also cancer prevention activities, and must therefore be prioritised and resourced in tandem. The projected volume of diabetes and cancer co-occurrence also has important policy implications in terms of workforce development, as well as service delivery. Cancer Epidemiology 13 December 2024
Geospatial patterns by cancer stage across Australia for three common cancers
Highlights
Cancer Epidemiology 26 December 2024
Impact of weighting on the association between sociodemographic characteristics, health behaviours and cancer, cardiovascular and all-cause mortality in the Australian 45 and Up Study
Highlights
Cancer Epidemiology 10 April 2024
Innovative use of Australian cancer registry data for early detection of the effects of epidemics and other mass disruptions on cancer incidence
Highlights
Cancer Epidemiology 5 July 2024
Out-of-pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross-sectional study
The known: Despite our universal health care system, the financial burden of medical costs can be great for people in Australia, particularly those with cancer.
The new: Out-of-pocket spending on health care during the preceding twelve months exceeded $1000 for 43% of survey respondents (aged 56 years or older). The likelihood of higher out-of-pocket expenses was greater for people with cancer, independent of the effect of socio-demographic factors.
The implications: High out-of-pocket costs can increase financial strain generally, but can also restrict access to appropriate health care for people with limited financial resources, especially for those with cancer. MJA 25 June 2024
Survival of patients who had cancer diagnosed through an emergency hospital admission: A retrospective matched case-comparison study in Australia
Highlights
Cancer Epidemiology 20 May 2024
__________________________________________________________________________________
Treatment and treatment related complications
Attributable risk and consequences of bone mineral density deficits in childhood cancer survivors
While treatment exposures were associated with long-term BMD deficits, modifiable risk factors, including smoking, sedentary behavior, hypogonadism, and growth hormone deficiency, suggest feasible targets for intervention. JAMA 10 January 2025
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study
What is already known on this topic
What this study adds
BMJ 20 August 2024
Evaluating cancer rehabilitation services: Insight from Australia and New Zealand
The survey identified key barriers and facilitators for the implementation of cancer rehabilitation programs. Collaborative efforts of relevant stakeholders, clinicians, consumers, and policymakers need to address barriers to broader implementation of cancer rehabilitation services. Journal of the International Society of Physical and Rehabilitation Medicine 29 August 2025
Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivors
Highlights
Cancer Epidemiology 7 November 2024
Towards precision cancer medicine for Aboriginal and Torres Strait Islander cancer health equity
Summary
MJA 1 July 2024
__________________________________________________________________________________
This is just a sample of the e-books the library subscribes to – you will need your library login
__________________________________________________________________________________
This is just a sample of the journals the library subscribes to – you will need your library login
__________________________________________________________________________________